Researchers led by Dr. Alex Lehrer at the University of Hawaii (UH) medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and now monkeys from the infection.
Dr. Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
Demonstrating the effectiveness of the vaccine candidate in monkeys (non-human primates) is an important milestone because it typically predicts the vaccine will work in humans, enabling further clinical development.
A strong global initiative to battle Zika has produced more than 30 vaccine candidates since outbreaks in 2015-2016 in Brazil linked the infection in some pregnant women to severe birth defects in their newborns. Zika is spread by the bite of infected mosquitos and through sex.
The proposed vaccine reported by scientists at the UH John A. Burns School of Medicine (JABSOM) in the journals Frontiers in Immunologyand mSphere, an open access journal of the American Society for Microbiology, is a recombinant subunit vaccine that uses only a small part (protein) of the Zika virus, produced in insect cells.
“We believe our vaccine candidate shows much promise particularly as it showed to require only two immunizations given three weeks apart and is a potentially safer alternative to other candidates already in clinical trials,” said Dr. Axel Lehrer, JABSOM (Assistant) Professor of Tropical Medicine and Infectious Disease.
Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
The research team at JABSOM included two senior graduate students who served as lead authors of the scientific research papers. Liana Medina, whose early training was directly supported by a National Institutes of Health Diversity in Health-Related Research grant, and Honolulu native Albert To are the graduate student lead authors.
Honolulu-based Hawai’i Biotech is a key partner in the vaccine development project with UH. Two of their scientists, Dr. Jaime Horton and David Clements, contributed to the most recent publication demonstrating vaccine efficacy in monkeys, along with collaborators from Bioqual Inc. of Rockville, Maryland, and the Department of Diagnostic Medicine/Pathobiology, Biosecurity Research Institute, College of Veterinary Medicine, at Kansas State University.
“The intense search for a Zika remedy since early 2016 has required us to be agile, and we believe our vaccine candidate research demonstrates that such quick-turnaround results can be achieved in academic and scientific partnerships here in Hawai’i,” said Dr. Lehrer. “It is incredibly gratifying that two of the scientists we are training to be the future of biomedical science played key roles in gathering, analyzing and reporting their conclusions. We hope Hawai’i’s citizens find that as inspiring as we do.”
Graduate student scientist and research co-author Liana Medina said there were chances to develop new skills at every step along the way. “Having the opportunity to see the vaccine’s development from its very first stages as Zika E protein being produced by Dr. Kenji Obadia, at the time also a student in our department, to a vaccine that is efficacious and safe in animal models was a unique learning experience. Being a part of the process allowed me grow as a student in this field,” said Medina.
Fellow graduate student and co-author Albert To said the team’s results “put us on the world-stage and highlight the talent we have here in Hawai?i.” He said, “Being involved with this project has given me a glimpse of the type of research and results needed to progress an idea to a potential preventative therapy used by thousands of people worldwide.”
The Latest on: Zika virus
via Google News
The Latest on: Zika virus
- Why Does COVID-19 Seem To Spare Africa? Zika May Have The Answerson November 20, 2020 at 12:37 pm
Why does a disease hit some countries or regions hard and largely spares others? For example, with COVID-19, the virus has surged so strongly in North and ...
- Why Does A Virus Cause Problems In One Region But Not Another? A Study Offers Insighton November 20, 2020 at 7:31 am
In 2015, the mosquito-borne virus Zika exploded in South America. Health experts predicted it would erupt in Africa. But a major outbreak never happened. Now scientists think they understand why.
- Global Zika Virus Market 2020 with Impact of COVID-19 Outbreak, SWOT Study, Steady Growth and Forecast 2026on November 20, 2020 at 5:07 am
Outbreak, SWOT Study, Steady Growth and Forecast 2026; Global Temperature Data-loggers Market 2020 with Impact ...
- Kinetic Modeling of West Nile Virus Fusion Indicates an Off-Pathway State.on November 20, 2020 at 12:12 am
West Nile virus (WNV) is a prominent mosquito-borne flavivirus that causes febrile illness in humans. To infect host cells, WNV virions first bind to plasma membrane receptors, then initiate membrane ...
- 'Domestication' increases mosquito's zika virus susceptibilityon November 19, 2020 at 11:25 am
The Aedes aegypti aegypti subspecies of mosquito, which has become a ''domestic'' pest worldwide, can acquire and transmit Zika virus more easily than its African forerunner.
- Greater mosquito susceptibility to Zika virus fueled the epidemicon November 19, 2020 at 11:02 am
The Zika virus has spread around the world over the last decade, causing millions of infections, some of which have been associated with congenital abnormalities and neurological disorders.
- Zika Virus Testing Market Research Report by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19on November 18, 2020 at 11:22 pm
The scope of the report includes a detailed study of Zika Virus Testing Market with the reasons given for variations in the growth of the industry in certain regions. Zika may be a flavivirus ...
- Global Zika Virus Vaccines Market 2020 Trending Technologies, Developments, Key Players and End-use Industry to 2026on November 12, 2020 at 4:54 am
MarketsandResearch.biz has published the latest and most trending report entitled Global Zika Virus Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 that collates ...
- Can Zika Virus Infection in High Risk Pregnant Women Be Differentiated on the Basis of Symptoms?on November 11, 2020 at 9:20 pm
Zika virus (ZIKV) infection in pregnancy is associated with congenital neurological abnormalities. Our understanding of the full clinical spectrum of ZIKV infection is incomplete. Using data from this ...
via Bing News